Royalty Pharma Stock Price

-0.27 (-0.57%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Royalty Pharma PLC RPRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.27 -0.57% 46.75 20:00:00
Open Price Low Price High Price Close Price Prev Close
46.81 45.80 47.40 46.57 47.02
Bid Price Ask Price Spread News
46.75 48.00 1.25 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
22,989 4,206,688 $ 46.53 $ 195,721,283 3,728,385 34.80 - 57.50
Last Trade Time Type Quantity Stock Price Currency
19:51:12 53 $ 46.90 USD

Royalty Pharma Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 29.23B 625.24M 285.69M $ 1.79B $ 1.56B 3.35 30.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 132.04% - -

more financials information »

Royalty Pharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RPRX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week46.9048.649945.5147.382,038,683-0.15-0.32%
1 Month48.5050.1745.0147.361,669,604-1.75-3.61%
3 Months42.2953.2342.0247.852,770,0134.4610.55%
6 Months41.746153.2334.8045.012,080,4335.0011.99%
1 Year45.9057.5034.8045.471,973,8330.851.85%
3 Years45.9057.5034.8045.471,973,8330.851.85%
5 Years0.82457.500.2622.561,114,03345.935,573.54%

Royalty Pharma Description

Royalty Pharma PLC is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company's portfolio consists of royalties on more than 45 marketed therapies and four development-stage product candidates. The therapies in portfolio address therapeutic areas such as rare diseases, oncology, neurology, HIV, cardiology and diabetes, and are delivered to patients across both primary and specialty care settings.

Your Recent History
Royalty Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.